Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Icodec with Flash Glucose Monitoring in Type 2 Diabetes
NCT05823948Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2023
- Primary completion
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin icodec in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Apr 2023; status: completed.
02
Drugs
insulin icodec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05823948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05823948.